Form 4 for CRL Charles River Laboratories
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001127602-24-005831 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-20 | 2024-02-15 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | M - OptEx | $144.67 | +5,882 | 8,478 | +227% | +$850.9K |
| DM | 2024-02-20 | 2024-02-15 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | S - Sale+OE | $241.20 | -5,882 | 4,038 | -59% | -$1.42M |
| D | 2024-02-20 | 2024-02-15 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | M - OptEx | $0.00 | -5,882 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | M | A | 5,882 | $144.67 | 8,478 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-15 | S | D | 89 | $245.34 | 2,596 | D | — | — | (F9) This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 3 | Common | Common Stock | 2024-02-15 | S | D | 749 | $244.61 | 2,685 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $244.27 to $45.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 4 | Common | Common Stock | 2024-02-15 | S | D | 604 | $243.96 | 3,434 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $243.26 to $244.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 5 | Common | Common Stock | 2024-02-15 | S | D | 610 | $241.28 | 4,670 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $240.83 to $241.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 6 | Common | Common Stock | 2024-02-15 | S | D | 1,617 | $240.12 | 5,280 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $239.76 to $240.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 7 | Common | Common Stock | 2024-02-15 | S | D | 1,290 | $239.28 | 6,897 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $238.73 to $239.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 8 | Common | Common Stock | 2024-02-15 | S | D | 291 | $237.20 | 8,187 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $236.71 to $237.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 9 | Common | Common Stock | 2024-02-15 | S | D | 632 | $242.43 | 4,038 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $241.97 to $242.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. |
| 10 | Derivative | Stock Options (Right to Buy) | 2024-02-15 | M | D | 5,882 | $0.00 | 0 | D | $144.67 · 2020-02-22 to 2024-02-22 | 5,882 Common Stock |